Bar Harbor Wealth Management Sells 992 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Bar Harbor Wealth Management reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 8.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 10,776 shares of the healthcare conglomerate's stock after selling 992 shares during the quarter. Bar Harbor Wealth Management's holdings in UnitedHealth Group were worth $5,644,000 as of its most recent filing with the SEC.

Several other institutional investors have also made changes to their positions in the stock. Financial Management Professionals Inc. boosted its holdings in shares of UnitedHealth Group by 0.8% during the first quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate's stock worth $1,165,000 after purchasing an additional 17 shares during the period. Richwood Investment Advisors LLC raised its position in UnitedHealth Group by 0.4% during the fourth quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate's stock valued at $2,654,000 after acquiring an additional 20 shares in the last quarter. Global Wealth Strategies & Associates raised its position in UnitedHealth Group by 28.6% during the first quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate's stock valued at $47,000 after acquiring an additional 20 shares in the last quarter. 44 Wealth Management LLC raised its position in UnitedHealth Group by 1.6% during the fourth quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate's stock valued at $662,000 after acquiring an additional 21 shares in the last quarter. Finally, Prentice Wealth Management LLC raised its position in UnitedHealth Group by 0.8% during the fourth quarter. Prentice Wealth Management LLC now owns 2,527 shares of the healthcare conglomerate's stock valued at $1,278,000 after acquiring an additional 21 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

Shares of NYSE:UNH traded down $5.11 on Friday, hitting $313.39. The stock had a trading volume of 13,729,200 shares, compared to its average volume of 7,185,786. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The firm's 50 day moving average price is $386.66 and its 200-day moving average price is $474.19. The company has a market capitalization of $284.28 billion, a price-to-earnings ratio of 20.22, a price-to-earnings-growth ratio of 1.37 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter in the prior year, the firm posted $6.91 EPS. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be given a dividend of $2.21 per share. The ex-dividend date is Monday, June 16th. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a yield of 2.82%. UnitedHealth Group's dividend payout ratio is presently 37.02%.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on UNH shares. Argus lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Monday, April 21st. Truist Financial reissued a "buy" rating and issued a $360.00 price target (down previously from $580.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Oppenheimer dropped their price target on shares of UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating on the stock in a research report on Wednesday, May 14th. Wells Fargo & Company reissued an "overweight" rating on shares of UnitedHealth Group in a research report on Friday, June 6th. Finally, TD Securities reaffirmed a "hold" rating and set a $308.00 target price (down previously from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $426.52.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,533 shares of the business's stock in a transaction on Wednesday, May 14th. The shares were bought at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the transaction, the director now owns 6,033 shares in the company, valued at approximately $1,935,386.40. This trade represents a 34.07% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Patrick Hugh Conway sold 589 shares of the company's stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the transaction, the chief executive officer now owns 10,398 shares in the company, valued at approximately $3,171,390. The trade was a 5.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have acquired 109,408 shares of company stock worth $31,607,768. Company insiders own 0.28% of the company's stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.